Acrivon Therapeutics所有资讯

Acrivon Therapeutics | 4：持股变动声明-高管 Miller Mary

04/19 16:15 (美东)

Acrivon Therapeutics | 4：持股变动声明-董事 RA CAPITAL MANAGEMENT, L.P.

04/15 16:20 (美东)

Acrivon Therapeutics | 4：持股变动声明-股东 PERCEPTIVE ADVISORS LLC

04/15 08:58 (美东)

Acrivon Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Perceptive Advisors LLC(17.4%),Joseph Edelman(17.4%)等

04/15 08:23 (美东)

Acrivon Therapeutics | SC 13D/A：超过5%持股股东披露文件(修正)-RA Capital Management, L.P.(27.1%),Peter Kolchinsky(27.1%)等

04/11 16:22 (美东)

Acrivon Therapeutics | 4：持股变动声明-董事 Palani Santhosh

03/06 16:36 (美东)

Acrivon Therapeutics | 3：首次持股声明-董事 Palani Santhosh

03/06 16:31 (美东)

Acrivon Therapeutics | 4：持股变动声明-高管 Masson Kristina

02/16 17:19 (美东)

Acrivon Therapeutics | 4：持股变动声明-高管 Miller Mary

02/16 17:18 (美东)

Acrivon Therapeutics | 4：持股变动声明-高管 Holm-Jorgensen Rasmus

02/16 17:17 (美东)

Acrivon Therapeutics | 4：持股变动声明-高管 Devroe Eric

02/16 17:13 (美东)

Acrivon Therapeutics | 4：持股变动声明-高管 Gamelin Erick

02/16 17:13 (美东)

Acrivon Therapeutics | 4：持股变动声明-高管 Blume-Jensen Peter

02/16 17:08 (美东)

Acrivon Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Perceptive Advisors LLC(13.6%),Joseph Edelman(13.6%)等

02/14 17:37 (美东)

Acrivon Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Citadel Advisors LLC(7.4%),Citadel Advisors Holdings LP(7.4%)等

02/14 17:02 (美东)

Acrivon Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Marshall Wace North America L.P.(2.7%)

02/14 09:57 (美东)

Acrivon Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Sands Capital Life Sciences Pulse Fund II, L.P.(7.4%),Sands Capital Ventures, LLC(7.4%)等

02/13 15:45 (美东)

Acrivon Therapeutics | 4：持股变动声明-董事 Magovcevic-Liebisch Ivana

02/09 16:41 (美东)

Acrivon Therapeutics | 3：首次持股声明-董事 Magovcevic-Liebisch Ivana

02/09 16:36 (美东)

Acrivon Therapeutics | 4：持股变动声明-高管 Miller Mary

01/19 00:00 (美东)